Viral hepatitis elimination program: taking the Micro-elimination path

The micro-elimination of HCV is the complete reduction of HCV infection to zero in targeted populations (e.g. PLHIV, prisoners, haemophiliacs), settings (e.g. hospitals), or limited geographic areas (e.g. Iceland). Substantial steps toward micro-elimination have already been undertaken in most high-income countries, typically focused on those with advanced liver disease. Ireland, for example, has effectively eradicated HCV in its hemophilia-patient population. In some countries, e.g. Australia, the Republic of Georgia, Iceland, Portugal and Spain, broader elimination efforts are well underway. To raise awareness on such accomplishments and boost the conversation surrounding the challenges to expanding HCV micro-elimination, the EILF is hosting a first closed door meeting (invitation only) during The International Liver Congress™ 2017 in view of working on the development of an action plan.

To learn more, read our editorial:

Viral Hepatitis Elimination

HEPATITIS C ELIMINATION IN KUWAIT: Recommendations

HEPATITIS C ELIMINATION IN KUWAIT: Recommendations

Final report of the EASL International Liver Foundation Expert Panel 11 December 2018 Kuwait

Education

THE EILF SCHOOL OF EXCELLENCE

THE EILF SCHOOL OF EXCELLENCE

THE EASL INTERNATIONAL LIVER FOUNDATION PROGRAMME FOR HIGH FLYERS. EILF have recently embarked on a collaboration with the Emirates Gastroenterology and Hepatology Society and together, we will hold the first School of Excellence on 28 September 2018 in Dubai. This full day interactive school will be led by EILF and local experts providing a mix of state of the art lectures, debates and clinical case presentations.

   

Learn more
Viral Hepatitis Elimination

VIRAL HEPATITIS ELIMINATION IN THE MIGRANT POPULATION

VIRAL HEPATITIS ELIMINATION IN THE MIGRANT POPULATION

The world is currently experiencing the greatest level of forced displacement that has ever been recorded with over 65 million people being forced from their homes in the past two decades. If the WHO’s viral hepatitis elimination targets are to be achieved then specialised programs and infrastructure will need to be scaled to specifically improve prevention, screening, and treatment of viral hepatitis among this ever growing and marginalised population.

  • 1 of 6

LEARN MORE ABOUT OUR INITIATIVES

To learn more about our initiatives contact us

Data Protection and Privacy Policy

EASL International Liver Foundation

We take the protection of your personal data seriously, meaning that we process your personal data with due care and in accordance with applicable data protection laws.

Consent

Please note that by clicking the box “I agree”, you explicitly agree to the processing of your personal data for the purposes and pursuant to the terms and conditions mentioned in our Data Protection and Privacy Policy available at here“.

Contact

For any question or request, please contact us at EASL International Live Foundation, Rue Daubin 7, 1203 Geneva, Switzerland, telephone 0041 (0)22 552 2497 gdpr@easl-ilf.org